NCT07765706 A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy Participants Status NOT_YET_RECRUITING Phase PHASE1
NCT07643155 A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment Status RECRUITING Phase PHASE1
NCT07481981 A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) Status RECRUITING Phase PHASE3
NCT07234032 An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Status RECRUITING Phase PHASE3
NCT07179380 Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Status RECRUITING Phase PHASE3
NCT07102316 A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2 (F2) to TPIP Formulation 3 (F3) in Healthy Participants Status COMPLETED Phase PHASE1
NCT06939647 An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Status AVAILABLE Phase N/A
NCT06685835 A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) Status TERMINATED Phase PHASE2
NCT06344728 A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants Status COMPLETED Phase PHASE1
NCT06238856 Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa Status COMPLETED Phase PHASE1
NCT06193031 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants Status COMPLETED Phase PHASE1
NCT06178783 A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants Status COMPLETED Phase PHASE1
NCT06091579 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants Status COMPLETED Phase PHASE1
NCT06013241 A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Status COMPLETED Phase PHASE2
NCT05999942 A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT05965570 A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants Status COMPLETED Phase PHASE1
NCT05927597 A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants Status COMPLETED Phase PHASE1
NCT05826574 A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants Status COMPLETED Phase PHASE1
NCT05673603 A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment Status COMPLETED Phase PHASE1